Distribution of Candida species in vaginal specimens and evaluation of CHROMagar Candida medium;Vajinal örneklerden izole edilen Candida suşlarιnιn daǧιlιmι ve CHROMagar Candida besiyerinin deǧerlendirilmesi

Mikrobiyoloji Bulteni

Volumn 39, Issue 3, 2005, Pages 319-324

  Gültekin, Berna ^a   Yazici, Vesile ^a   Aydin, Neriman ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Candida spp; CHROMagar; Vulvovaginal candidiasis

Indexed keywords

ARTICLE; CANDIDA; CLASSIFICATION; CULTURE MEDIUM; EVALUATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; STANDARD; VAGINA; VAGINA CANDIDIASIS;

CANDIDA; CANDIDIASIS, VULVOVAGINAL; CULTURE MEDIA; FEMALE; HUMANS; VAGINA;

EID: 33846452203     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tümbay E: Candida türleri, s. 1081-1086. Ustaçelebi Ş (ed), Temel ve Klinik Mikrobiyoloji. 1999, Güneş Kitabevi, Ankara.
2. Segal E, Elad D: Candida species and Blastoschizomyces capitatus, p. 423-460. In: Collier L, Balows A, Susman M (eds), Topley & Wilson's Microbiology and Microbial Infections. 1998, 9th ed. Oxford University Press, New York.
3. Rein MF: Vulvovaginitis and cervicitis, p. 1218-1235. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Pennsylvania.
4. Rex JH, Walsh TJ, Sobel JD, et al: Practice guidelines for the treatment of candidiasis. Clin Infect Dis. 2000, 30: 662-678.
5. Baumgartner C, Freydiere AM, Gille Y: Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin Microbiol 1996, 34: 454-456.
6. Pfaller MA, Houston A, Coffmann S: Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.J Clin Microbiol 1996, 34: 58-61.
7. Koehler AP, Chu KC, Houang ET, Cheng AF: Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 1999, 37: 422-426.
8. Quan M: Vaginitis: Meeting the clinical challenge. Clinical Cornerstone 2000, 3: 36-47.
9. Landers DV, Wiesenfeld HC, Heine RP, Krohn MA, Hillier SL: Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004, 190: 1004-1010.
10. Ferrer J: Vaginal candidosis: Epidemiological and etiological factors. Int J Gynaecol Obstet 2000, 71: 21-27.
11. Spinillo A, Pizzoli G, Colonna L, Nicola S, De Seta F, Guaschino S: Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol 1993, 81: 721-727.
12. Fidel PL Jr, Vazquez JA, Sobel JD: Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to Candida albicans. Clin Microbiol Rev 1999, 12: 80-86.
13. Spinillo A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi G: Torulopsis glabrata vaginitis. Obstet Gynecol 1995, 85: 993-998.
14. Arikan S, Hasçlik G, Günalp A: Hacettepe Üniversitesi hastanelerinde klinik örneklerden izole edilen maya türleri. İnfeksiyon Derg 1998, 12: 97-102.
15. Tünger Ö, Özbakkaloǧlu B, Ecemiş T, Koyuncu F: Vulvovajinitli kadinlarda maya mantarlarinin sikliǧi ve türlere göre daǧilimi. Türk Mikrobiyol Cem Derg 2000, 30: 127-130.
16. del Palacio A, Sanz F, Sanchez-Alor G, et al: Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-release cream (1, 2 and 4%) with placebo site-release vaginal cream. Mycoses 2000, 43: 355-365.
17. Corosello S, Spinillo A, Osnengo G, et al: An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 2003, 10: 66-72.
18. Berrouane YF, Hollis RJ, Pfaller MA: Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J Clin Microbiol 1996, 34: 1856-1858.
19. Hospenthal DR, Murray CK, Rinaldi MG: The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis 2004, 48: 153-160.
20. Odds FC, Bernaerts R: CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994, 32: 1923-1929.
21. Yucesoy M, Marol S: Performance of CHROMagar Candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob 2003, 29: 8.
22. Fotedar R, al-Hedaithy SS: Identification of chlamydospore-negative Candida albicans using CHROMagar Candida medium. Mycoses 2003, 46: 96-103.
23. Willinger B, Manafi M: Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses 1999, 42: 61-65.
24. Hospenthal DR, Murray CK, Beckius ML, Green JA, Dooley DP: Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium. J Clin Microbiol 2002, 40: 4768-4770.
25. Beighton D, Ludford R, Clark DT, et al: Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 1995, 33: 3025-3027.
26. Jabra-Rizk MA, Baqui M, Kelley jl, Falkler WA Jr, Merz WG, Meiller TF: Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 1999, 37: 321-326.
27. Willinger B, Hillowoth C, Selitsch B, Manafi M: Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 2001, 39: 3793-3795.
28. Horvath LL, Hospenthal DR, Murray CK, Dooley DP: Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida. J Clin Microbiol 2003, 41: 2629-2632.
29. Powell HL, Sand CA, Rennie RP: Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn Microbiol Infect Dis 1998, 32: 201-204.